Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016 (2016), Article ID 2164329, 3 pages
http://dx.doi.org/10.1155/2016/2164329
Case Report

Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban

1Haemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, Belgium
2Division of Haematology, University Hospital Centre Zagreb, Medical School of Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia

Received 18 February 2016; Revised 2 June 2016; Accepted 15 June 2016

Academic Editor: Simon Davidson

Copyright © 2016 Ana Boban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet’s disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our findings are promising; the outcome was favourable without any adverse effect noted. We propose that the patients with Behçet’s disease and venous thrombosis might benefit from the advantages of the new anticoagulant drug.